Lorraine Spector

Array ( [id] => 7473749 [patent_doc_number] => 20040121953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Thrombopoiesis-stimulating proteins having reduced immunogenicity' [patent_app_type] => new [patent_app_number] => 10/638995 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17834 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121953.pdf [firstpage_image] =>[orig_patent_app_number] => 10638995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325047 [patent_doc_number] => 20040138114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Compositions and methods for the treatment of immune related diseases' [patent_app_type] => new [patent_app_number] => 10/614853 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 34979 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138114.pdf [firstpage_image] =>[orig_patent_app_number] => 10614853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448079 [patent_doc_number] => 07250161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Equine GM-CSF' [patent_app_type] => utility [patent_app_number] => 10/614481 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5219 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250161.pdf [firstpage_image] =>[orig_patent_app_number] => 10614481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6968889 [patent_doc_number] => 20050235374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method' [patent_app_type] => utility [patent_app_number] => 10/517028 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4414 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20050235374.pdf [firstpage_image] =>[orig_patent_app_number] => 10517028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725091 [patent_doc_number] => 20030207403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Beta-like glycoprotein hormone polypeptide and heterodimer' [patent_app_type] => new [patent_app_number] => 10/449140 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38104 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207403.pdf [firstpage_image] =>[orig_patent_app_number] => 10449140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876822 [patent_doc_number] => 07358341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Beta-like glycoprotein hormone polypeptide and heterodimer' [patent_app_type] => utility [patent_app_number] => 10/448771 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37718 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358341.pdf [firstpage_image] =>[orig_patent_app_number] => 10448771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678525 [patent_doc_number] => 20030228666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Novel human thrombopoietin mutein' [patent_app_type] => new [patent_app_number] => 10/441729 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9715 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228666.pdf [firstpage_image] =>[orig_patent_app_number] => 10441729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134720 [patent_doc_number] => 20040043424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Immunoglobulin superfamily proteins' [patent_app_type] => new [patent_app_number] => 10/432103 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39144 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043424.pdf [firstpage_image] =>[orig_patent_app_number] => 10432103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 445605 [patent_doc_number] => 07252967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Nucleic acids encoding cytokine-like proteins that promote cell proliferation' [patent_app_type] => utility [patent_app_number] => 10/440066 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10597 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/252/07252967.pdf [firstpage_image] =>[orig_patent_app_number] => 10440066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730197 [patent_doc_number] => 20030186387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Interleukins-21 and 22' [patent_app_type] => new [patent_app_number] => 10/397282 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77887 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186387.pdf [firstpage_image] =>[orig_patent_app_number] => 10397282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829833 [patent_doc_number] => 20030180891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Connective tissue growth factor-4' [patent_app_type] => new [patent_app_number] => 10/394015 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 74520 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180891.pdf [firstpage_image] =>[orig_patent_app_number] => 10394015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4554851 [patent_doc_number] => 07820793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'IFN-λ polypeptides and compositions' [patent_app_type] => utility [patent_app_number] => 10/503866 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 27 [patent_no_of_words] => 61998 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820793.pdf [firstpage_image] =>[orig_patent_app_number] => 10503866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161070 [patent_doc_number] => 20050084850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Bone marrow secreted proteins and polynucleotides' [patent_app_type] => utility [patent_app_number] => 10/347669 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23076 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084850.pdf [firstpage_image] =>[orig_patent_app_number] => 10347669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 846935 [patent_doc_number] => 07384634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Connective tissue growth factor' [patent_app_type] => utility [patent_app_number] => 10/338587 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 18550 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384634.pdf [firstpage_image] =>[orig_patent_app_number] => 10338587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797024 [patent_doc_number] => 20030175898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Biological material and uses thereof' [patent_app_type] => new [patent_app_number] => 10/204653 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11735 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175898.pdf [firstpage_image] =>[orig_patent_app_number] => 10204653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111095 [patent_doc_number] => 07718177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/315568 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17862 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718177.pdf [firstpage_image] =>[orig_patent_app_number] => 10315568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314925 [patent_doc_number] => 20040034192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Human proteins having hyprophobic domains and dnas encoding these proteins' [patent_app_type] => new [patent_app_number] => 10/169395 [patent_app_country] => US [patent_app_date] => 2002-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 27606 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034192.pdf [firstpage_image] =>[orig_patent_app_number] => 10169395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711817 [patent_doc_number] => 20030171566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Basal cell carcinoma tumor suppressor gene' [patent_app_type] => new [patent_app_number] => 10/302279 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 37999 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171566.pdf [firstpage_image] =>[orig_patent_app_number] => 10302279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399689 [patent_doc_number] => 20040023337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'IL-13 mutein proteins, antibodies, compositions, methods and uses' [patent_app_type] => new [patent_app_number] => 10/280645 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 35061 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023337.pdf [firstpage_image] =>[orig_patent_app_number] => 10280645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163061 [patent_doc_number] => 20050085412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Gonadotrophins for folliculogenesis' [patent_app_type] => utility [patent_app_number] => 10/493638 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11308 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085412.pdf [firstpage_image] =>[orig_patent_app_number] => 10493638 [rel_patent_id] =>[rel_patent_doc_number] =>)